edited by Adriana Petryna, Andrew Lakoff, and Arthur Kleinman.
Durham :
Duke University Press,
2006.
301 pages :
illustrations ;
24 cm
Includes bibliographical references (pages 263-287) and index.
Globalizing human subjects research / Adriana Petryna -- The new medical oikumene / David Healy -- Educating for global mental health: the adoption of SSRIs in Japan / Kalman Applbaum -- High contact: gifts and surveillance in Argentina / Andrew Lakoff -- Addiction markets: the case of high-dose buprenorphine in France / Anne M. Lovell -- Pharmaceuticals in urban ecologies: the register of the local / Veena Das and Ranendra K. Das -- Pharmaceutical governance / Joøo Biehl -- Treating AIDS: dilemmas of unequal access in Uganda / Susan Reynolds Whyte, Lotte Meinert, and Betty Kyaddondo.
0
In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption. Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals.